Trinity Biotech Enters Collaboration With Intradermal Drug Delivery Platform Maker Latch Medical
The collaboration is intended to combine data streams from Trinity Biotech's CGM+ wearable biosensor platform with Latch Medical's advanced drug delivery technologies to evaluate the development of precision
Trinity Biotech is teaming up with another company to combine their technology—one that tracks body signals and one that delivers medicine—to see if they can work better together. When companies partner up like this, it shows they believe in new possibilities, but we won't know if it actually works until later.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.